Earlier SGLT-2 inhibitors for type 2 diabetes could cut deaths, says NICE
image: ©Halfpoint | iStock New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for…
RNA-targeting small molecules: a new frontier of drug discovery
Historically, drug discovery has centred around proteins but as targets become increasing saturated, novel RNA-targeting drugs indicate potential…
This Pharma Giant Is Using AI to Dominate Drug Discovery
There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
FDA rejects drug for rare blood disorder
The US Food and Drug Administration has rejected a small molecule for a rare blood disorder called…
Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
UnitedHealth shrinks, Medicare Advantage crackdown: Health Care Inc.
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software
By Sneha S K Jan 9 (Reuters) – Schrodinger said on Friday it is collaborating with Eli Lilly…
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
Countries used to test drugs often don’t see the approved medicines, study finds
Numerous medicines are not accessible in many of the countries where they were tested before approval by the…